Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06492746 · ClinicalTrials.gov registry record · NA
Personal BP - CAI Study
A NA study of Blood Pressure, sponsored by Edwards Lifesciences.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06492746: Recruiting NA study of Blood Pressure, sponsored by Edwards Lifesciences.
NCT06492746 is a NA study of Blood Pressure that is actively recruiting participants, run by Edwards Lifesciences. The registered enrollment target is 120 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06492746, a NA study of Blood Pressure, is actively recruiting participants, sponsored by Edwards Lifesciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets
Primary Outcome
To determine the sum of the product of magnitude and duration that CAI during cardiopulmonary bypass (CPB) is at or above the threshold of 45 during current standard of care and assess the incidence of CAI ≥45 in the absence of decreased cerebral StO2 or MAP thresholds.
Conditions Studied
Interventions
- DEVICE HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring
Study Locations (1)
Illinois
- Northwestern University Hospital - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06492746 shows while recruiting
NCT06492746 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring is the first listed.
NCT06492746 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06492746 about?
NCT06492746 is a clinical study titled "Personal BP - CAI Study". A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets
What is the current status of trial NCT06492746?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-06-03. Estimated completion is 2025-12.
What conditions does trial NCT06492746 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT06492746?
The interventions under investigation include: HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring (DEVICE).
Who is sponsoring clinical trial NCT06492746?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06492746 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06492746's enrollment target sits among peer trials
120 32nd of 101 higher than 68 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI